SEARCH

SEARCH BY CITATION

References

  • 1
    Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with non-alcoholic fatty liver disease. N Engl J Med 2010;363:13411350.
  • 2
    Boulé NG, Haddad E, Kenny GP, Wells GA, Sigal RJ. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA 2001;286:12181227.
  • 3
    Umpierre D, Ribeiro PA, Kramer CK, Leitão CB, Zucatti AT, Azevedo MJ, et al. Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis. JAMA 2011;305:17901799.
  • 4
    Thoma C, Day CP, Trenell MI. Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review. J Hepatol 2012;56:255266.
  • 5
    Rodriguez B, Torres DM, Harrison SA. Physical activity: an essential component of lifestyle modification in NAFLD. Nat Rev Gastroenterol Hepatol 2012; 9:726731.
  • 6
    Bonekamp S, Barone BB, Clark J, Stewart KJ. The effect of an exercise training intervention on hepatic steatosis [Abstract]. Hepatology 2008;48:806A.
  • 7
    Lazo M, Solga SF, Horska A, Bonekamp S, Diehl AM, Brancati FL, et al., Fatty Liver Subgroup of the Look AHEAD Research Group. Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes. Diabetes Care 2010;33:21562163.
  • 8
    Albu JB, Heilbronn LK, Kelley DE, Smith SR, Azuma K, Berk ES, et al., Look AHEAD Adipose Research Group. Metabolic changes following a 1-year diet and exercise intervention in patients with type 2 diabetes. Diabetes 2010;59:627633.
  • 9
    Tamura Y, Tanaka Y, Sato F, Choi JB, Watada H, Niwa M, et al. Effects of diet and exercise on muscle and liver intracellular lipid contents and insulin sensitivity in type2 diabetic patients. J Clin Endocrinol Metab 2005;90:31913196.
  • 10
    Bacchi E, Negri C, Zanolin ME, Milanese C, Faccioli N, Trombetta M, et al. Metabolic effects of aerobic training and resistance training in type 2 diabetic subjects: a randomized controlled trial (the RAED2 study). Diabetes Care 2012;35:676682.
  • 11
    Karvonen JJ, Kentala E, Mustala O. The effects of training on heart rate; a longitudinal study. Ann Med Exp Biol Fenn 1957;35:307315.
  • 12
    Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499502.
  • 13
    Lee JK, Dixon WT, Ling D, Levitt RG, Murphy WA Jr. Fatty infiltration of the liver: demonstration by proton spectroscopic imaging. Preliminary observations. Radiology 1984;153:195201.
  • 14
    Fishbein MH, Gardner KG, Potter CJ, Schmalbrock P, Smith MA. Introduction of fast MR imaging in the assessment of hepatic steatosis. Magn Reson Imaging 1997;15:287293.
  • 15
    Targher G, Rossi AP, Zamboni GA, Fantin F, Antonioli A, Corzato F, et al. Pancreatic fat accumulation and its relationship with liver fat content and other fat depots in obese individuals. J Endocrinol Invest 2012;35:748753.
  • 16
    Szczepaniak LS, Nuremberg P, Leonard D, Nuremberg P, Browning JD, Reingold JS, et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 2005;288:E462E468.
  • 17
    McPherson S, Jonsson JR, Cowin GJ, O'Rourke P, Clouston AD, Volp A, et al. Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered. J Hepatol 2009;51:389397.
  • 18
    Kang BK, Yu ES, Lee SS, Lee Y, Kim N, Sirlin CB, et al. Hepatic fat quantification: a prospective comparison of magnetic resonance spectroscopy and analysis methods for chemical-shift gradient echo magnetic resonance imaging with histologic assessment as the reference standard. Invest Radiol 2012;47:368375.
  • 19
    Cassidy FH, Yokoo T, Aganovic L, Hanna RF, Bydder M, Middleton MS, et al. Fatty liver disease: MR imaging techniques for the detection and quantification of liver steatosis. Radiographics 2009;29:231260.
  • 20
    Shen W, Wang ZM, Punyanita M, Lei J, Sinay A, Kral JG, et al. Adipose tissue quantification by imaging methods: a proposed classification. Obes Res 2003;11:515.
  • 21
    Johnson D, Dixon AK, Abrahams PH. The abdominal subcutaneous tissue: computed tomographic, magnetic resonance, and anatomical observations. Clin Anat 1996;9:1924.
  • 22
    Johnson NA, Sachinwalla T, Walton DW, Smith K, Armstrong A, Thompson MW, et al. Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. Hepatology 2009;50:11051112.
  • 23
    Bozzetto L, Prinster A, Annuzzi G, Costagliola L, Mangione A, Vitelli A, et al. Liver fat is reduced by an isoenergetic MUFA diet in a controlled randomized study in type 2 diabetic patients. Diabetes Care 2012;35:14291435.
  • 24
    Hallsworth K, Fattakhova G, Hollingsworth KG, Thoma C, Moore S, Taylor R, et al. Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss. Gut 2011;60:12781283.
  • 25
    Harrison SA, Day CP. Benefits of lifestyle modification in NAFLD. Gut 2007;56:17601769.
  • 26
    Magkos F. Exercise and fat accumulation in the human liver. Curr Opin Lipidol 2010;21:507517.
  • 27
    Zelber-Sagi S, Nitzan-Kaluski D, Goldsmith R, Webb M, Zvibel I, Goldiner I, et al. Role of leisure-time physical activity in non-alcoholic fatty liver disease: a population-based study. Hepatology 2008;48:17911798.
  • 28
    Miyazaki Y, Glass L, Triplitt C, Wajcberg E, Mandarino LJ, DeFronzo RA. Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 2002;283:E11351143.
  • 29
    Sniderman AD, Bhopal R, Prabhakaran D, Sarrafzadegan N, Tchernof A. Why might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesis. Int J Epidemiol 2007;36:220225.
  • 30
    Golan R, Shelef I, Rudich A, Gepner Y, Shemesh E, Chassidim Y, et al. Abdominal superficial subcutaneous fat: a putative distinct protective fat subdepot in type 2 diabetes. Diabetes Care 2012;35:640647.
  • 31
    Schwenzer NF, Springer F, Schraml C, Stefan N, Machann J, Schick F. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol 2009;51:433445.
  • 32
    Reeder SB, Cruite I, Hamilton G, Sirlin CB. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging 2011;34:729749.
  • 33
    Colberg SR, Sigal RJ, Fernhall B, Regensteiner JG, Blissmer BJ, et al., American College of Sports Medicine; American Diabetes Association. Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement. Diabetes Care 2010;33:e147e167.